We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Research compound — not a dietary supplement
17-Alpha-Estradiol is a research compound, not a regulated dietary supplement. It is sold for research or off-label use. The evidence below is largely preclinical (animal and in-vitro) or early-stage, so no evidence score is assigned. This page is provided for transparency and education — it is not a recommendation to use. Consult a qualified healthcare provider, and be aware that purity, dosing, and legal status vary by jurisdiction.
What the evidence says
Most 17-Alpha-Estradiol studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality studies published 2016–2024.
Based on 4 studies
Confidence
Very lowBy outcome
The current evidence for 17-Alpha-Estradiol is insufficient to assign an evidence score, based on 4 indexed studies. A 'non-feminizing' stereoisomer of estradiol that extended lifespan in male mice in the NIA aging program — with little estrogenic (feminizing) activity. Honest appraisal: the evidence is entirely animal, the benefit is male-specific (it can harm female reproductive aging), and there are no human data. A research compound, not an approved drug or supplement. Representative study: PMID 27312235.
The commonly studied dose of 17-Alpha-Estradiol is No validated human dose. The mouse studies delivered it in food at defined ppm; grey-market oral dosing for longevity is anecdotal and unsupported by any human data.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Last reviewed June 2026 · evidence from 4 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
17α-Estradiol (non-feminizing estrogen)
A 'non-feminizing' stereoisomer of estradiol that extended lifespan in male mice in the NIA aging program — with little estrogenic (feminizing) activity. Honest appraisal: the evidence is entirely animal, the benefit is male-specific (it can harm female reproductive aging), and there are no human data. A research compound, not an approved drug or supplement.
17α-Estradiol reproducibly extended lifespan in male mice with minimal feminizing activity, but the evidence is entirely animal, the benefit is male-specific (and can harm female reproductive aging), and there are no human data — so it is a preclinical-only research compound.
17α-Estradiol is the alpha stereoisomer of the main human estrogen 17β-estradiol.
Its interest in geroscience comes from a striking property: in the NIA Interventions Testing Program it extended lifespan in male mice while having minimal classical estrogenic (feminizing) activity — hence 'non-feminizing estrogen.' Mechanistic work suggests it improves metabolic and inflammatory markers of aging in males, reduces adipose-tissue inflammation, and acts partly through estrogen-receptor-beta and brain/hypothalamic signaling, in a way that depends on intact gonads (it largely fails to extend lifespan in castrated males).
The honest evidence picture is narrow: all efficacy data are in mice, the benefit is male-specific (and at least one study found it promotes ovarian aging in females), and there are no human pharmacokinetic, efficacy, or safety studies for longevity.
It is not an approved human drug in most markets (a related compound, alfatradiol, is used topically for hair loss), so grey-market '17α-estradiol' sold for longevity is an unregulated research chemical of uncertain purity, with unknown human dosing and long-term hormonal effects.
The score reflects an interesting, reproducible male-mouse lifespan result with zero human data and real sex-specific caveats.
The alpha stereoisomer has low affinity for classical estrogen receptors, giving metabolic/longevity effects in males with minimal feminization.
Reduces adipose-tissue inflammation and improves insulin sensitivity and metabolic markers in aged male mice.
Effects appear to act partly via estrogen-receptor-beta and brain signaling, and require intact gonads (sex-specific).
How 17-Alpha-Estradiol works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
No validated human dose. The mouse studies delivered it in food at defined ppm; grey-market oral dosing for longevity is anecdotal and unsupported by any human data.
Can be taken without food
| Form | Type |
|---|---|
| 💊None established (research compound) | Recommended |
Not an approved human longevity drug; topical alfatradiol (a related use) is for androgenetic alopecia, not longevity.
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: No validated human timing; all dosing guidance is extrapolated from rodent diets.
Dose-response data unavailable. The current published research for 17-Alpha-Estradiol does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Extended lifespan in male mice with minimal feminization — not shown in humans, and not seen the same way in females.
Improved insulin sensitivity and lowered inflammation in aged male rodents.
No human pharmacokinetic, efficacy, or safety studies for longevity exist.
Benefit is male-specific; it can promote ovarian aging in females, and long-term hormonal effects in humans are unknown.
Avoid — benefit is male-specific and it can promote ovarian aging in models.
Avoid — it is still an estrogen stereoisomer with uncharacterized human activity.
Research-use-only; no human validation.
Tip: No human safety data; long-term endocrine effects unquantified.
Timing is flexible for 17-Alpha-Estradiol — consistent daily use matters more than the time of day. No validated human dosing or schedule; research-use-only compound.
17-Alpha-Estradiol should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are unknown human hormonal effects. Use caution if any of these apply to you: Pregnancy / breastfeeding; Women (sex-specific harms; promotes ovarian aging in models); Hormone-sensitive conditions.
Fermented rice containing natural statins that effectively lower LDL cholesterol — the original statin.